Marc A. Dall'Era MD

Surgical Oncology

Professor, and Chair of the Department of Urologic Surgery at UC Davis School of Medicine

4860 Y StreetSuite 3500Sacramento, CA 95864
Phone+1 916-734-2893

Dr. Dall'Era is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Dall'Era's full profile Already have an account?

Summary

Marc Dall'Era, MD is a Urology specialist with a subspecialty in Surgical Oncology based in Sacramento, CA. He completed his residency in Surgery and Urology at the University of Washington and is part of the class of 2000 from the University of California, Davis, School of Medicine. Dr. Dall'Era is experienced in Urologic Oncology and has contributed significantly to the field through various publications. He has also been involved in clinical trials studying High Risk Localized Prostate Cancer and Non Muscle Invasive Bladder Cancer. His work has been recognized with the CMS Meaningful Use Stage 1 Certification from EpicCare Ambulatory EMR, Epic Systems Corporation in 2011-2012.

Education & Training

University of WashingtonResidency, Urology, 2000 - 2006
University of WashingtonResidency, Surgery, 2000 - 2002
University of California, Davis, School of MedicineClass of 2000

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

CA State Medical License 2006 - 2028
FL State Medical License 2021 - 2023
WA State Medical License 2000 - 2006
American Board of Urology Urology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012-2014, 2016-2017
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012-2014, 2016-2017
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012

Clinical Trials

Efficacy Study of Recombinant Adenovirus for Non Muscle Invasive Bladder Cancer Start of enrollment: 2014 Mar 01
Terminated
Phase 2, Phase 3
Niraparib Before Surgery in Treating Patients With High Risk Localized Prostate Cancer and DNA Damage Response Defects Start of enrollment: 2020 Feb 25
TERMINATED
PHASE2

Publications & Presentations

PubMed

5 citations
Impact of Maximal Transurethral Resection on Pathological Outcomes at Cystectomy in a Large, Multi-institutional Cohort.
Peter S Kirk, Yair Lotan, Homayoun Zargar, Adrian S Fairey, Colin P Dinney
The Journal of Urology. 2023-05-01
6 citations
Multicenter evaluation of neoadjuvant and induction gemcitabine-carboplatin versus gemcitabine-cisplatin followed by radical cystectomy for muscle-invasive bladder can...
Sarah M H Einerhand, Anna J Black, Homayoun Zargar, Adrian S Fairey, Colin P Dinney
World Journal of Urology. 2022-11-01
24 citations
Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment
Yu Jiang, Travis J. Meyers, Adaeze A. Emeka, Lauren Folgosa Cooley, Phillip R. Cooper
HGG Advances. 2021-11-18